SCHEMBL2853928

SCHEMBL2853928

COc1ccc(-c2cnc(Cl)c(C(O)C3=CCCCC3=O)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
THRB P10828 1/20 0.38
GRIN1 Q05586 4/20 0.36
GRIN2B Q13224 4/20 0.36
MAP4K4 O95819 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CHEK2 O96017 1/20 0.34
PDGFRB P09619 1/20 0.34
PDGFRA P16234 1/20 0.34
PARP1 P09874 1/20 0.34
KDM4E B2RXH2 1/20 0.34
JAK2 O60674 1/20 0.34
HPGD P15428 1/20 0.34
CHRNA7 P36544 1/20 0.33
CA12 O43570 1/20 0.33
CA9 Q16790 1/20 0.33
CYP3A4 P08684 1/20 0.33
ALOX15 P16050 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2851190 0.94 ALDH1A1 (0.56) ALDH1A1GRIN1GRIN2BMAP4K4MEN1
SCHEMBL2851463 0.86 THRB (0.42) ALDH1A1THRBGRIN2BMAP4K4PDGFRB
SCHEMBL4896922 0.85 PDGFRB (0.36) ALDH1A1GRIN1GRIN2BMAP4K4MEN1
SCHEMBL2853181 0.79 ALDH1A1 (0.38) ALDH1A1THRBGRIN2BMAP4K4PDGFRB
SCHEMBL2853925 0.74 PDGFRB (0.38) ALDH1A1GRIN1GRIN2BPDGFRBPDGFRA
SCHEMBL2853090 0.69 ALDH1A1 (0.39) ALDH1A1THRB
SCHEMBL2878634 0.68 CYP2C19 (0.39) ALDH1A1THRBMEN1KMT2AKDM4E
SCHEMBL3557121 0.68 THRB (0.39) ALDH1A1THRBPARP1KDM4EHPGD
SCHEMBL2853101 0.67 KDM4E (0.40) ALDH1A1GRIN1GRIN2BMAP4K4CHEK2
SCHEMBL13500082 0.67 CYP3A4 (0.39) ALDH1A1THRBCYP3A4ALOX15HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7666883-B2 2-[(2-Chloro-5-methyl pyridine-3-yl)(hydroxy)methyl]acrylonitrile; against chloroquine sensitive and chloroquine resistant Plasmodium falciparum; treating malarial; chemical preparation COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2010-02-23 US claimed
EP-1924558-B1 AN ANTIMALARIAL BAYLIS-HILLMAN ADDUCTS AND A PROCESS FOR THE PREPARATION THEREOF COUNCIL SCIENT IND RES (IN) 2010-01-13 EP claimed
US-20070117822-A1 Novel antimalarial baylis-hillman adducts and a process for the preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2007-05-24 US claimed
US-7666883-B2 2-[(2-Chloro-5-methyl pyridine-3-yl)(hydroxy)methyl]acrylonitrile; against chloroquine sensitive and chloroquine resistant Plasmodium falciparum; treating malarial; chemical preparation COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2010-02-23 US disclosed
EP-1924558-B1 AN ANTIMALARIAL BAYLIS-HILLMAN ADDUCTS AND A PROCESS FOR THE PREPARATION THEREOF COUNCIL SCIENT IND RES (IN) 2010-01-13 EP disclosed
EP-1924558-A1 AN ANTIMALARIAL BAYLIS-HILLMAN ADDUCTS AND A PROCESS FOR THE PREPARATION THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2008-05-28 EP disclosed
US-20070117822-A1 Novel antimalarial baylis-hillman adducts and a process for the preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2007-05-24 US disclosed
WO-2007032016-A1 AN ANTIMALARIAL BAYLIS-HILLMAN ADDUCTS AND A PROCESS FOR THE PREPARATION THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2007-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070117822-A1 Novel antimalarial baylis-hillman adducts and a process for the preparation thereof HBS1L, SSBP1, QARS1 ALDH1A1 1459/4885THRB 4830/4885GRIN1 1446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.